Microbial Pathogenesis, Год журнала: 2025, Номер unknown, С. 107724 - 107724
Опубликована: Май 1, 2025
Язык: Английский
Microbial Pathogenesis, Год журнала: 2025, Номер unknown, С. 107724 - 107724
Опубликована: Май 1, 2025
Язык: Английский
European Journal of Medicinal Chemistry Reports, Год журнала: 2025, Номер unknown, С. 100269 - 100269
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Asian Journal of Chemistry, Год журнала: 2025, Номер 37(5), С. 1224 - 1228
Опубликована: Апрель 30, 2025
Development of microbial resistance against commercial imidazoles intended present study to develop some new metronidazole analogues cellulitis causing pathogens. In study, N-(4-substituted benzylidene)-2-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)-acetohydrazide (2a-c) were synthesized by treating hydrazide derivative (1) with various aromatic aldehydes. The structures compounds 2a-c characterized using FT-IR, 1H NMR, 13C NMR and mass spectrometric data. evaluated for their inhibitory potential triggering bacteria S. aureus, E. coli cell viability profile MTT assay. Among 2a-c, compound 2c incorporated high electronegative group, exhibited maximum This was also supported the docking data glucosamine-6-phosphate (2VF5). significant antibacterial aureus coli, HEK 293 cells (more than 75%) score 2VF5 supports application in treatment. However, should be further vivo preclinical significance.
Язык: Английский
Процитировано
0Microbial Pathogenesis, Год журнала: 2025, Номер unknown, С. 107724 - 107724
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0